| RS1909596551 |
SCN4A
|
Health Risk |
Pathogenic |
Hyperkalemic periodic paralysis, Hyperkalemic periodic paralysis |
| RS1909597270 |
SCN4A
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 16, Congenital myasthenic syndrome 16 |
| RS190961216 |
MFN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1909619442 |
SMAD4
|
Health Risk |
Pathogenic |
Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1909619692 |
SMAD4
|
Health Risk |
Pathogenic |
Juvenile polyposis syndrome, Juvenile polyposis syndrome |
| RS1909650741 |
SCN4A
|
Health Risk |
Pathogenic |
Hyperkalemic periodic paralysis, Hyperkalemic periodic paralysis |
| RS190965235 |
FLCN
|
Health Risk |
Conflicting classifications of pathogenicity |
Birt-Hogg-Dube syndrome, Hereditary cancer-predisposing syndrome |
| RS190967471 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS190968346 |
TPO
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of iodide peroxidase, Deficiency of iodide peroxidase |
| RS1909702747 |
ACSF3
|
Health Risk |
Pathogenic |
Combined malonic and methylmalonic acidemia, Combined malonic and methylmalonic acidemia |
| RS190972540 |
SKIC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Trichohepatoenteric syndrome 2, SKIC2-related disorder |
| RS190978463 |
CHD8
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, CHD8-related disorder |
| RS190979363 |
TG
|
Health Risk |
Conflicting classifications of pathogenicity |
Iodotyrosyl coupling defect, Ovarian serous cystadenocarcinoma |
| RS1909795937 |
SMAD4
|
Health Risk |
Pathogenic |
Juvenile polyposis syndrome, Juvenile polyposis syndrome |
| RS1909795990 |
SMAD4
|
Health Risk |
Likely pathogenic |
Generalized juvenile polyposis/juvenile polyposis coli, Generalized juvenile polyposis/juvenile polyposis coli |
| RS1909818289 |
GALNS
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-IV-A |
| RS1909820489 |
GALNS
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-IV-A |
| RS1909823551 |
ATP8B1
|
Health Risk |
Pathogenic |
Benign recurrent intrahepatic cholestasis type 1, Benign recurrent intrahepatic cholestasis type 1 |
| RS1909832718 |
GALNS
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-IV-A |
| RS1909882416 |
SUZ12
|
Health Risk |
Pathogenic |
— |
| RS190988309 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2C, Febrile seizures |
| RS1909895611 |
SMAD4
|
Health Risk |
Likely pathogenic |
Generalized juvenile polyposis/juvenile polyposis coli, Juvenile polyposis syndrome |
| RS1909899495 |
SMAD4
|
Health Risk |
Likely pathogenic |
Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome |
| RS1909901558 |
SMAD4
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Hereditary cancer-predisposing syndrome |
| RS1909906368 |
SMAD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Juvenile polyposis syndrome, Hereditary cancer-predisposing syndrome |
| RS190991689 |
GDPD2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1909920019 |
DCC
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1909920586 |
DCC
|
Health Risk |
Likely pathogenic |
Mirror movements 1, Mirror movements 1 |
| RS1909936773 |
SUZ12
|
Health Risk |
Pathogenic |
Imagawa-Matsumoto syndrome, Imagawa-Matsumoto syndrome |
| RS190997558 |
KIF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 30, Neuropathy |
| RS190997924 |
OTOGL
|
Health Risk |
Likely pathogenic |
Rare genetic deafness, Rare genetic deafness |
| RS190999087 |
PDE6B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Retinal dystrophy |
| RS191002419 |
COL4A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Alport syndrome, Alport syndrome |
| RS191003311 |
ERLIN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, ERLIN2-related disorder |
| RS191009474 |
SCN5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital long QT syndrome, Brugada syndrome 1 |
| RS191012363 |
NEBL
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary dilated cardiomyopathy, Primary dilated cardiomyopathy |
| RS191014566 |
KMT2A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS191015656 |
ANKRD26
|
Health Risk |
Conflicting classifications of pathogenicity |
Thrombocytopenia 2, ANKRD26-related disorder |
| RS1910183166 |
SMAD4
|
Health Risk |
Pathogenic |
Colorectal cancer, Colorectal cancer |
| RS1910186100 |
SMAD4
|
Health Risk |
Pathogenic |
Juvenile polyposis syndrome, Juvenile polyposis syndrome |
| RS191021194 |
CDH23
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 12, Usher syndrome type 1D |
| RS1910352953 |
GALNS
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-IV-A |
| RS1910353907 |
GALNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-IV-A |
| RS1910359431 |
GALNS
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-IV-A |
| RS191036195 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS191036710 |
PLEC
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa simplex, Ogna type |
| RS191037362 |
LRRCC1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1910419866 |
GAN
|
Health Risk |
Pathogenic |
Giant axonal neuropathy 1, Giant axonal neuropathy 1 |
| RS191042013 |
ABCB11
|
Health Risk |
Conflicting classifications of pathogenicity |
ABCB11-related disorder, ABCB11-related disorder |
| RS1910429809 |
GAN
|
Health Risk |
Pathogenic/Likely pathogenic |
Giant axonal neuropathy 1, Giant axonal neuropathy 1 |
| RS1910478581 |
SMAD4
|
Health Risk |
Pathogenic |
Juvenile polyposis syndrome, Juvenile polyposis syndrome |
| RS1910480814 |
SMAD4
|
Health Risk |
Pathogenic/Likely pathogenic |
Generalized juvenile polyposis/juvenile polyposis coli, Hereditary cancer-predisposing syndrome |
| RS1910484768 |
SMAD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, Myhre syndrome |
| RS191051353 |
GPI
|
Health Risk |
Conflicting classifications of pathogenicity |
Hemolytic anemia due to glucophosphate isomerase deficiency, Hemolytic anemia due to glucophosphate isomerase deficiency |
| RS1910517904 |
SMAD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Juvenile polyposis syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1910518741 |
SMAD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Juvenile polyposis syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS191054704 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS191057574 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS191057824 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1910631809 |
GALNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-IV-A |
| RS1910636198 |
GALNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-IV-A |
| RS1910644710 |
GALNS
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-IV-A |
| RS1910655109 |
RGS9
|
Health Risk |
Likely pathogenic |
— |
| RS1910656890 |
RGS9
|
Health Risk |
Pathogenic |
— |
| RS191068215 |
SPINK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tropical pancreatitis, Hereditary pancreatitis |
| RS191072842 |
NAV1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS191074858 |
ZNF335
|
Health Risk |
Conflicting classifications of pathogenicity |
ZNF335-related disorder, ZNF335-related disorder |
| RS191075257 |
CYP7B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 5A, Hereditary spastic paraplegia 5A |
| RS1910760503 |
GAN
|
Health Risk |
Pathogenic |
Giant axonal neuropathy 1, Giant axonal neuropathy 1 |
| RS191078968 |
WRN
|
Health Risk |
Likely pathogenic |
Werner syndrome, Werner syndrome |
| RS191081055 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
CHARGE syndrome, Inborn genetic diseases |
| RS191081991 |
DST
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary sensory and autonomic neuropathy type 6, Epidermolysis bullosa simplex 3 |
| RS191083003 |
FSIP2
|
Health Risk |
Pathogenic |
Spermatogenic failure 34, Spermatogenic failure 34 |
| RS1910941663 |
RGS9
|
Health Risk |
Pathogenic |
— |
| RS1910973930 |
GALNS
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-IV-A |
| RS1910994325 |
PRPF8
|
Health Risk |
Pathogenic |
— |
| RS1910994795 |
PRPF8
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1911000715 |
PRPF8
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1911000944 |
PRPF8
|
Health Risk |
Pathogenic |
— |
| RS1911001854 |
PRPF8
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 13, Retinal disorder |
| RS1911004419 |
PRPF8
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1911029601 |
PRPF8
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 13, Retinitis pigmentosa 13 |
| RS191104356 |
MCPH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly 1, primary |
| RS191105001 |
FRAS1
|
Health Risk |
Conflicting classifications of pathogenicity |
FRAS1-related disorder, FRAS1-related disorder |
| RS191107774 |
CPT1A
|
Health Risk |
Likely pathogenic |
Carnitine palmitoyl transferase 1A deficiency, Carnitine palmitoyl transferase 1A deficiency |
| RS1911079646 |
PRPF8
|
Health Risk |
Pathogenic |
— |
| RS1911081749 |
PRPF8
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS191109849 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Lynch syndrome, Hereditary cancer-predisposing syndrome |
| RS191115811 |
HLCS
|
Health Risk |
Conflicting classifications of pathogenicity |
Holocarboxylase synthetase deficiency, HLCS-related disorder |
| RS1911196248 |
PRPF8;RILP
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinitis pigmentosa |
| RS191125006 |
TMEM237
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome 14, Joubert syndrome 14 |
| RS191128410 |
FANCM
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia |
| RS1911322255 |
PRPF8
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinal dystrophy |
| RS1911391944 |
PRPF8
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Inborn genetic diseases |
| RS191145030 |
LRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Donnai-Barrow syndrome, Inborn genetic diseases |
| RS191145848 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypobetalipoproteinemia 1, Hypercholesterolemia |
| RS191148548 |
SPG11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 11, Inborn genetic diseases |
| RS1911505318 |
PRPF8
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 13, Retinitis pigmentosa 13 |
| RS1911510393 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS191151467 |
SPTA1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |